Back to FDA Applications sponsored by LANTHEUS MEDCL

FDA Drug Application 021064 by LANTHEUS MEDCL

Application Number021064
Application Type New Drug Application
Sponsor ApplicantLANTHEUS MEDCL
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP07/31/2001N1653000 7/31/2001
AP07/31/2001N4670000 7/31/2001
AP07/31/2001N4671000 7/31/2001
AP07/31/2001N6910000 11/20/2003
AP02/21/2002SLR1652001 2/21/2002
AP07/8/2002SLR1651002 7/8/2002
AP01/30/2003SCI8884004 6/2/2004
AP05/6/2005SLR18182006 10/4/2007
AP010/10/2007SLR18209007 10/10/2007
AP010/10/2007SLR18239007 10/15/2007
AP05/12/2008SLR19831009 5/14/2008
AP05/12/2008SLR19941009 6/5/2008
AP010/24/2011SE830409011 10/25/2011
AP010/24/2011SE830426011 10/26/2011
AP010/24/2011SE833434011 8/14/2012
AP010/24/2011SE833435011 8/14/2012
AP08/18/2015SLR43677017 8/19/2015
AP08/18/2015SLR43678017 8/20/2015

Back to FDA Applications sponsored by LANTHEUS MEDCL

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.